0886 516 705 office@healthpr.bg
  • Български
  • English
Health PR
  • Home
  • ABOUT US
    • Health PR principles
    • Competence
    • Areas of expertise
    • Partners
    • Team
    • SERVICES
    • PRIVACY POLICY
      • GENERAL TERMS AND CONDITIONS OF THE WEBSITE OF HEALTH PR
      • HEALTH PR COOKIES POLICY
      • PRIVACY POLICY
  • NEWS
  • CONTACTS
Select Page
Pharma sales rep salary survey finds annual incomes rising, but COVID-19 concerns mounting

Pharma sales rep salary survey finds annual incomes rising, but COVID-19 concerns mounting

by admin | Jun 15, 2020 | news

An annual survey of pharma sales rep salaries showed another year-over-year increase, but it also revealed concerns about the impact of the COVID-19 pandemic. Salaries averaged more than $150,000 in 2019, for an increase of 6%. However, three-fourths of the pharma...
Coronavirus tracker: T cells could provide hint to how Roche’s Actemra treats COVID-19 patients

Coronavirus tracker: T cells could provide hint to how Roche’s Actemra treats COVID-19 patients

by admin | May 4, 2020 | news

A new study out of China has tied T cell activation to Roche’s IL-6 inhibitor Actemra, which has shown some early effect in treating cytokine storm in severe COVID-19 patients. Meanwhile, the National Institutes of Health has kicked off a “Shark...
Blue Cross MN CEO: Why COVID-19 may be making the case for value-based care

Blue Cross MN CEO: Why COVID-19 may be making the case for value-based care

by admin | May 2, 2020 | news

COVID-19 is making the case for accelerating the move to more value-based models of care.  Hospitals’ financial struggles as they pause elective procedures during the pandemic highlight the weaknesses in a volume-based system, said Craig Samitt, M.D., CEO of...
Trump tries to lure CureVac to make a ‘U.S. vaccine,’ but German government steps in

Trump tries to lure CureVac to make a ‘U.S. vaccine,’ but German government steps in

by admin | Mar 16, 2020 | news

It’s a pretty extraordinary story that started off with a CEO exiting a biotech and has now become about the U.S. president allegedly wanting to lure that biotech over to the U.S. to build a vaccine for the coronavirus—but just for Americans.   Maybe it was...
True innovation or just later to market? German agency questions benefits of new drugs

True innovation or just later to market? German agency questions benefits of new drugs

by admin | Jul 15, 2019 | news

When a new drug is approved, the developer usually trumpets its ability to fill an unmet medical need. But a German agency that evaluates the quality of medical treatments disagrees is calling for an international reform of drug development and approval. In...
« Older Entries
Next Entries »

FAST LINKS

  • ABOUT US
  • SERVICES
  • EVENTS
  • NEWS
  • CONTACTS

LATEST POSTS

  • More Than Half of Doctors Now Part of Healthcare Systems 10/08/2021
  • CureVac’s mRNA coronavirus shot boasts one advantage over Pfizer and Moderna counterparts—refrigerated storage 19/04/2021
  • More anti-epidemic measures eased today 19/04/2021

CONTACTS

agsdi-location

Sofia 1000, 15 Prof. Fritiof Nansen Blvd,
ent. B, floor 1

agsdi-gmail

office@healthpr.bg



0886 516 705

All rights reserved 2018 © HealthPR | design: syreia+

We use cookies! The data collected by cookies provides you with a better experience on our website. A detailed description is given in the Privacy Policy and the Cookie Policy.OKNoLearn more